Notices. Notice
324 words·~1 min read·
/register/2000/10/31/00-27835·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4160-01-F DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Advisory Committee; Renewals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is announcing the renewals of certain FDA advisory committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed below for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed below. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Pubic Law 92-463 (5 U.S.C. app. 2)). DATES: Authority for these committees will expire on the dates indicated below unless the Commissioner formally determines that renewal is in the public interest. Name of committee Date of expiration Gastrointestinal Drugs Advisory Committee March 3, 2002 Advisory Committee for Reproductive Health Drugs March 23, 2002 Arthritis Advisory Committee April 5, 2002 Veterinary Medicine Advisory Committee April 24, 2002 Anesthetic and Life Support Drugs Advisory Committee May 1, 2002 Blood Products Advisory Committee May 13, 2002 Pulmonary-Allergy Drugs Advisory Committee May 30, 2002 Drug Abuse Advisory Committee May 31, 2002 Science Advisory Board to the National Center for Toxicological Research June 2, 2002 Peripheral and Central Nervous System Drugs Advisory Committee June 4, 2002 Psychopharmacologic Drugs Advisory Committee June 4, 2002 Transmissible Spongiform Encephalopathies Advisory Committee June 9, 2002 Science Board to the Food and Drug Administration June 26, 2002 Allergenic Products Advisory Committee July 9, 2002 Cardiovascular and Renal Drugs Advisory Committee August 27, 2002 Endocrinologic and Metabolic Drugs Advisory Committee August 27, 2002 Oncologic Drugs Advisory Committee September 1, 2002 FOR FURTHER INFORMATION CONTACT: Donna M. Combs, Committee Management Office (HFA-306), Food and Drug Administration, 5600 Fishers Lane, Rockville MD 20857, 301-827-5496. Dated: October 23, 2000. Linda A. Suydam, Senior Associate Commissioner. [FR Doc. 00-27835 Filed 10-30-00; 8:45 am]